'Hidden' factors influencing quality of life in patients with multiple sclerosis

European Journal of Neurology

Volumn 22, Issue , 2015, Pages 28-33

  Lysandropoulos, A P ^a   Havrdova, E ^b  

^a ERASME HOSPITAL   (Belgium)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cognitive function; Multiple sclerosis; Patient centred outcomes; Psychological therapies; Quality of life; Sexual function

Indexed keywords

CLINICAL PRACTICE; COGNITION; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DISEASE ACTIVITY; FATIGUE; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RELAPSE; REVIEW; SEXUAL DYSFUNCTION; SEXUALITY; SOCIAL ISOLATION; WELLBEING; COMPLICATION; OUTCOME ASSESSMENT; PROCEDURES; PSYCHOLOGY; STANDARDS;

HUMANS; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE;

EID: 84941631984     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12801     Document Type: Review

References (25)

1. Krahn TM. Care ethics for guiding the process of multiple sclerosis diagnosis. J Med Ethics 2014; 40: 802-806.
2. Lorefice L, Mura G, Coni G, et al. What do multiple sclerosis patients and their caregivers perceive as unmet needs? BMC Neurol 2013; 13: 177.
3. Hankomäki E, Multanen J, Kinnunen E, Hämäläinen P. The progress of cognitive decline in newly diagnosed MS patients. Acta Neurol Scand 2014; 129: 184-191.
4. Glanz B, Healy BC, Hviid LE, Chitnis T, Weiner HL. Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. J Neurol Neurosurg Psychiatry 2012; 83: 38-43.
5. Sumowski JF, Leavitt VM. Cognitive reserve in multiple sclerosis. Mult Scler 2013; 19: 1122-1127.
6. Sumowski JF, Leavitt VM, Cohen A, Paxton J, Chiaravalloti ND, DeLuca J. Retrieval practice is a robust memory aid for memory-impaired patients with MS. Mult Scler 2013; 19: 1943-1946.
7. Bronner G, Elran E, Golomb J, Korczyn AD. Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention. Acta Neurol Scand 2010; 121: 289-301.
8. Prévinaire JG, Lecourt G, Soler JM, Denys P. Sexual disorders in men with multiple sclerosis: evaluation and management. Ann Phys Rehabil Med 2014; 57: 329-336.
9. Schairer LC, Foley FW, Zemon V, et al. The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis. Mult Scler 2014; 20: 610-616.
10. Oreja-Guevara C, Wiendl H, Kieseier BC, Airas L; NeuroNet Study Group. Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner. Ther Adv Neurol Disord 2014; 7: 137-149.
11. Rintell D, Melito R. 'Her illness is a project we can work on together': developing a collaborative family-centered intervention model for newly diagnosed multiple sclerosis. Int J MS Care 2013; 15: 130-136.
12. European Medicines Agency. Guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/10/WC500133438.pdf (accessed 14/07/2014)
13. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Manual and Interpretation Guide. The Health Institute, New England Medical Center: Boston, 1993.
14. Hobart J, Freeman J, Lamping D, Fitzpatrick R, Thompson A. The SF-36 in multiple sclerosis: why basic assumptions must be tested. J Neurol Neurosurg Psychiatry 2001; 71: 363-370.
15. Doward LC, McKenna SP, Meads DM, Twiss J, Eckert BJ. The development of patient-reported outcome indices for multiple sclerosis (PRIMUS). Mult Scler 2009; 15: 1092-1102.
16. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001; 124: 962-973.
17. Simeoni M, Auquier P, Fernandez O, et al. Validation of the Multiple Sclerosis International Quality of Life questionnaire. Mult Scler 2008; 14: 219-230.
18. Devy R, Lehert P, Varlan E, Genty M, Edan G. A short and validated multiple sclerosis-specific health-related quality of life measurement for routine medical practice. Eur J Neurol 2013; 20: 935-941.
19. Wicks P, Massagli M, Kulkarni A, Dastani H. Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ). J Med Internet Res 2011; 13: e12.
20. Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev 2006: CD004431.
21. Simpson R, Booth J, Lawrence M, Byrne S, Mair F, Mercer S. Mindfulness based interventions in multiple sclerosis - a systematic review. BMC Neurol 2014; 14: 15.
22. Nordin L, Rorsman I. Cognitive behavioural therapy in multiple sclerosis: a randomized controlled pilot study of acceptance and commitment therapy. J Rehabil Med 2012; 44: 87-90.
23. Holmes JM, Ford E, Yuill F, Drummond AE, Lincoln NB. Attendance at a psychological support group for people with multiple sclerosis and low mood. Disabil Rehabil 2012; 34: 1323-1327.
24. D'Hooghe MB, Nagels G, De Keyser J, Haentjens P. Self-reported health promotion and disability progression in multiple sclerosis. J Neurol Sci 2013; 325: 120-126.
25. Mohr DC, Lovera J, Brown T, et al. A randomized trial of stress management for the prevention of new brain lesions in MS. Neurology 2012; 79: 412-419.